Metropolitan Life Insurance Company (MetLife)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,163
| Closed | -$25M | – | 1181 |
|
|
2024
Q1 | $25M | Sell |
32,163
-296
| -0.9% | -$211K | 1.09% | 13 |
|
|
2023
Q4 | $18.9M | Sell |
32,459
-534
| -2% | -$312K | 0.89% | 18 |
|
|
2023
Q3 | $17.7M | Sell |
32,993
-1,344
| -4% | -$693K | 0.92% | 17 |
|
|
2023
Q2 | $16.1M | Sell |
34,337
-938
| -3% | -$393K | 0.78% | 20 |
|
|
2023
Q1 | $12.1M | Sell |
35,275
-8,489
| -19% | -$2.86M | 0.62% | 25 |
|
|
2022
Q4 | $16M | Sell |
43,764
-1,522
| -3% | -$540K | 0.72% | 23 |
|
|
2022
Q3 | $14.6M | Sell |
45,286
-556
| -1% | -$176K | 0.69% | 22 |
|
|
2022
Q2 | $14.9M | Sell |
45,842
-1,489
| -3% | -$447K | 0.65% | 25 |
|
|
2022
Q1 | $13.6M | Sell |
47,331
-74,089
| -61% | -$19.1M | 0.48% | 34 |
|
|
2021
Q4 | $33.5M | Sell |
121,420
-3,611
| -3% | -$915K | 0.46% | 32 |
|
|
2021
Q3 | $28.9M | Sell |
125,031
-4,360
| -3% | -$1.08M | 0.42% | 38 |
|
|
2021
Q2 | $29.7M | Sell |
129,391
-12,893
| -9% | -$2.59M | 0.42% | 34 |
|
|
2021
Q1 | $26.6M | Sell |
142,284
-8,034
| -5% | -$1.57M | 0.4% | 43 |
|
|
2020
Q4 | $25.4M | Sell |
150,318
-6,127
| -4% | -$915K | 0.38% | 45 |
|
|
2020
Q3 | $23.2M | Sell |
156,445
-12,076
| -7% | -$1.87M | 0.39% | 45 |
|
|
2020
Q2 | $27.7M | Buy |
168,521
+2,774
| +2% | +$426K | 0.49% | 32 |
|
|
2020
Q1 | $23M | Sell |
165,747
-2,370
| -1% | -$326K | 0.47% | 38 |
|
|
2019
Q4 | $22.1M | Sell |
168,117
-1,109
| -0.7% | -$129K | 0.35% | 54 |
|
|
2019
Q3 | $18.9M | Buy |
169,226
+13,752
| +9% | +$1.53M | 0.32% | 59 |
|
|
2019
Q2 | $17.2M | Buy |
155,474
+9,281
| +6% | +$1.09M | 0.29% | 64 |
|
|
2019
Q1 | $19M | Sell |
146,193
-18,527
| -11% | -$2.25M | 0.34% | 58 |
|
|
2018
Q4 | $19.1M | Sell |
164,720
-4,046
| -2% | -$452K | 0.38% | 44 |
|
|
2018
Q3 | $18.1M | Sell |
168,766
-5,188
| -3% | -$519K | 0.31% | 64 |
|
|
2018
Q2 | $14.8M | Sell |
173,954
-19,862
| -10% | -$1.63M | 0.24% | 73 |
|
|
2018
Q1 | $15M | Buy |
193,816
+279
| +0.1% | +$22.5K | 0.21% | 71 |
|
|
2017
Q4 | $16.3M | Sell |
193,537
-309,952
| -62% | -$26.4M | 0.22% | 67 |
|
|
2017
Q3 | $43.1M | Sell |
503,489
-8,588
| -2% | -$704K | 0.27% | 62 |
|
|
2017
Q2 | $42.1M | Sell |
512,077
-8,337
| -2% | -$680K | 0.29% | 58 |
|
|
2017
Q1 | $43.8M | Sell |
520,414
-7,586
| -1% | -$608K | 0.3% | 55 |
|
|
2016
Q4 | $38.8M | Sell |
528,000
-13,486
| -2% | -$1M | 0.28% | 65 |
|
|
2016
Q3 | $43.5M | Sell |
541,486
-6,688
| -1% | -$535K | 0.32% | 53 |
|
|
2016
Q2 | $43.2M | Sell |
548,174
-6,245
| -1% | -$470K | 0.32% | 53 |
|
|
2016
Q1 | $39.9M | Sell |
554,419
-10,045
| -2% | -$760K | 0.31% | 59 |
|
|
2015
Q4 | $47.6M | Sell |
564,464
-6,915
| -1% | -$574K | 0.37% | 51 |
|
|
2015
Q3 | $47.8M | Sell |
571,379
-10,269
| -2% | -$867K | 0.34% | 55 |
|
|
2015
Q2 | $48.6M | Buy |
581,648
+40,657
| +8% | +$3.1M | 0.34% | 54 |
|
|
2015
Q1 | $39.3M | Sell |
540,991
-8,248
| -2% | -$587K | 0.29% | 67 |
|
|
2014
Q4 | $37.9M | Sell |
549,239
-14,654
| -3% | -$989K | 0.26% | 74 |
|
|
2014
Q3 | $36.6M | Sell |
563,893
-9,178
| -2% | -$581K | 0.26% | 72 |
|
|
2014
Q2 | $35.6M | Sell |
573,071
-37,110
| -6% | -$2.21M | 0.25% | 82 |
|
|
2014
Q1 | $35.9M | Sell |
610,181
-12,815
| -2% | -$715K | 0.25% | 82 |
|
|
2013
Q4 | $31.8M | Buy |
622,996
+2,480
| +0.4% | +$124K | 0.22% | 91 |
|
|
2013
Q3 | $31.2M | Sell |
620,516
-3,681
| -0.6% | -$193K | 0.24% | 84 |
|
|
2013
Q2 | $30.7M | Buy |
+624,197
| New | +$34M | 0.24% | 83 |
|
Other funds holding LLY
Metropolitan Life Insurance Company (MetLife)'s LLY Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 32,163 shares — an estimated $25M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in LLY in Q2 2013 and held it in 44 quarters. The position peaked at $48.6M in Q2 2015. 3,566 funds tracked by Wall St. Rank hold LLY as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 32,163 Eli Lilly shares in Q2 2024, an estimated $25M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Eli Lilly in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Eli Lilly position peaked at $48.6M in Q2 2015.
- 3,566 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.